Biocartis could get up to €24mm in debt financing
Related Biotechnology, Pharmaceutical and Healthcare News
Biocartis Group NV (molecular diagnostics for cancer and infectious diseases) secured up to €24mm ($29.3mm) in a two-tran...
Original Article: Biocartis could get up to €24mm in debt financing
NEXT ARTICLE
More From BioPortfolio on "Biocartis could get up to €24mm in debt financing"
